Tempest Therapeutics, Inc. (TPST) SEC Filings — 2025
16 SEC filings for Tempest Therapeutics, Inc. (TPST) in 2025.
Filings
- Tempest Therapeutics Seeks Shareholder Approval for Key Strategic Moves — DEF 14A · Dec 31, 2025
- Tempest Files S-1 for Resale of 1.17M Shares by Warrant Holders — S-1 · Dec 9, 2025
- Tempest Therapeutics Files 8-K on Equity Sales — 8-K · Nov 26, 2025
- Tempest Therapeutics Files DEFA14A — DEFA14A · Nov 19, 2025
- Tempest's Cash Dwindles Amid Strategic Review, R&D Cuts — 10-Q · Nov 5, 2025
- Tempest's Q2 Net Loss Widens to $20.5M Amid R&D Spend — 10-Q · Aug 11, 2025
- Tempest Therapeutics Files 8-K with Material Agreement — 8-K · Jun 12, 2025
- Tempest Therapeutics Relocates Principal Executive Offices — 8-K · Jun 11, 2025
- Tempest Therapeutics Files 8-K on Leadership and Compensation Changes — 8-K · Jun 6, 2025
- Tempest Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Tempest Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
- Tempest Therapeutics Files 8-K — 8-K · Apr 28, 2025
- Tempest Therapeutics Reports Exit Costs — 8-K · Apr 18, 2025
- Tempest Therapeutics Terminates Material Agreement — 8-K · Apr 9, 2025
- Tempest Therapeutics Files 8-K on Security Holder Rights — 8-K · Apr 7, 2025
- Tempest Therapeutics Files 2024 10-K — 10-K · Mar 27, 2025